BNP PARIBAS FINANCIAL MARKETS - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 90 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.6%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$169,305
+69.0%
91,516
+1.4%
0.00%
Q4 2022$100,187
-99.8%
90,259
+354.1%
0.00%
Q3 2022$46,510,000
+68.4%
19,876
+118.1%
0.00%
Q2 2022$27,618,000
-9.5%
9,115
+102.9%
0.00%
Q1 2022$30,501,000
-72.5%
4,492
-66.2%
0.00%
Q4 2021$110,863,000
+58.6%
13,277
+41.2%
0.00%
Q3 2021$69,887,000
+211.2%
9,406
+184.8%
0.00%
Q2 2021$22,460,000
-72.1%
3,303
-57.8%
0.00%
Q1 2021$80,383,000
+267.0%
7,827
+150.1%
0.00%
Q4 2020$21,903,000
-28.2%
3,129
-16.3%
0.00%
Q3 2020$30,494,000
+405.6%
3,737
+327.6%
0.00%
Q2 2020$6,031,000
-74.9%
874
-82.7%
0.00%
Q1 2020$24,040,000
-29.4%
5,061
+29.8%
0.00%
Q4 2019$34,047,000
+294.9%
3,900
+50.6%
0.00%
Q3 2019$8,621,000
-32.9%
2,589
-0.2%
0.00%
Q2 2019$12,840,000
-38.0%
2,594
-22.3%
0.00%
Q1 2019$20,696,000
+1443.3%
3,338
+738.7%
0.00%
Q4 2018$1,341,000
-67.5%
398
-37.3%
0.00%
Q3 2018$4,128,000
-47.6%
635
-38.3%
0.00%
Q2 2018$7,882,000
-88.8%
1,029
-67.2%
0.00%
Q1 2018$70,112,000
+99.2%
3,137
+13.7%
0.00%
Q4 2017$35,190,000
+259.1%
2,760
+338.8%
0.00%
Q3 2017$9,800,000
+4.9%
629
-5.6%
0.00%
Q2 2017$9,344,0006660.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TRV GP II, LLC 10,230,349$63,428,00041.36%
TRV GP III, LLC 3,048,780$18,902,0009.26%
Omega Fund Management, LLC 1,059,930$6,572,0001.39%
Alambic Investment Management, L.P. 50,622$314,0000.13%
Spark Investment Management LLC 244,300$1,514,0000.07%
ALGERT GLOBAL LLC 14,182$88,0000.05%
Redmile Group, LLC 254,590$1,578,0000.05%
Granahan Investment Management 125,533$778,0000.04%
GSA CAPITAL PARTNERS LLP 38,602$239,0000.02%
Frontier Wealth Management LLC 27,099$168,0000.02%
View complete list of JOUNCE THERAPEUTICS INC shareholders